Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Glioblastoma 28Lung Neoplasms 13Gliosarcoma 13Carcinoma, Non-Small-Cell Lung 13Rectal Neoplasms 12Brain Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Sarcoma 9Prostatic Neoplasms 9Breast Neoplasms 9Astrocytoma 9Uterine Cervical Neoplasms 8Melanoma 8Glioma 8Esophageal Neoplasms 8Pancreatic Neoplasms 7Head and Neck Neoplasms 7Neoplasm Metastasis 5Lymphoma, Follicular 5Oropharyngeal Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Squamous Cell 4Stomach Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Mouth Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma, B-Cell 3

Interventions

Doxorubicin 3pembrolizumab 2Radiotherapy 2ribociclib 1peposertib 1montanide ISA 51 1liposomal doxorubicin 1itacitinib 1futibatinib 1cixutumumab 1belinostat 1baricitinib 1avelumab 1Specimen Handling 1Radiation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-2 1Ifosfamide 1INCB039110 1Histamine H2 Antagonists 1Fluorouracil 1Famotidine 1Erlotinib Hydrochloride 1Chemotherapy, Adjuvant 1Celecoxib 1Biopsy 1BO-112 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Histiocytoma, Malignant Fibrous × Radiation × Clear all
NCT04420975 2026-03-10

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Jonsson Comprehensive Cancer Center

Phase 1 Active not recruiting
14 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡